Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1373/CLINCHEM.2004.040485PMID 15514090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism.

  2003cited by this paper
• Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure.

  2003cited by this paper
• Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays.

  2002cited by this paper
• Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.

  2002cited by this paper
• Human PTH-(7-84) Inhibits Bone Resorption in Vitro Via Actions Independent of the Type 1 PTH/PTHrP Receptor.

  2002cited by this paper
• Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid Function

  2001cited by this paper
• Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.

  2001cited by this paper
• Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells.

  2001cited by this paper
• Receptors for the Carboxyl-Terminal Region of PTH(1-84) Are Highly Expressed in Osteocytic Cells* *This work was supported by the NIH Grant DK-11794.

  2001cited by this paper
• Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays.

  2000cited by this paper
• A novel mechanism for skeletal resistance in uremia.

  2000cited by this paper
• A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.

  1999cited by this paper
• A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples.

  1998cited by this paper
• Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.

  1996cited by this paper
• Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84)

  1995cited by this paper
• Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions.

  1993cited by this paper
• Carboxylterminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other causes of hypercalcemia

  1992cited by this paper
• Use of octadecasilyl-silica for the extraction and purification of peptides in biological samples. Application to the identification of circulating metabolites of corticotropin-(1-24)-tetracosapeptide and somatostatin in vivo.

  1977cited by this paper

• Parathyroid hormone assay standardization in CKD-MBD: resolving heterogeneity for precision medicine

  2025cites this paper
• High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity.

  2022cites this paper
• Hypoparathyroidism: Genetics and Diagnosis

  2022cites this paper
• Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications

  2019cites this paper
• SON DÖNEM KRONİK BÖBREK YETMEZLİĞİNDE PARATİROİD BEZLERİNİN ULTRASONOGROFİK BOYUTLARININ KALSİYUM METABOLİZMASI VE KEMİK DÖNGÜSÜ İLE İLİŞKİSİ VE ERİTROPOETİN TEDAVİSİNİN ROLÜ

  2019cites this paper
• TYPES, MANIFESTATIONS, AND CAUSES OF HYPOPARATHYROIDISM

  2019cites this paper
• Rapid electrochemical device for single-drop point-of-use screening of parathyroid hormone

  2019cites this paper
• Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.

  2018cites this paper
• Primarni hipoparatireoidizam u djece

  2018cites this paper
• Clinical presentation and management of hypoparathyroidism.

  2018cites this paper
• PTH assays in dialysis patients: Practical considerations

  2018cites this paper
• Biochemical Testing Relevant to Bone.

  2017cites this paper
• Hypoparathyroidism

  2017cites this paper
• Bioanalytical Studies of the Assessment of Vitamin D Status

  2017cites this paper
• Epidemiology and Diagnosis of Hypoparathyroidism.

  2016cites this paper
• Chapter 56 – Parathyroid Hormone and the Parathyroid Hormone Receptor Type 1 in the Regulation of Calcium and Phosphate Homeostasis and Bone Metabolism

  2016cites this paper
• Structure of non-( 184 ) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism

  2015cites this paper
• Metabolismo mineral y óseo: visión general y sus métodos de medición

  2015cites this paper
• Metabolism and Measurement of Parathyroid Hormone

  2015cites this paper
• Parathyroid Hormone (PTH) Assays and Applications to Bone Disease: Overview on Methodology

  2015cites this paper
• A lower proportion of circulating active parathyroid hormone in peritoneal dialysis does not allow the pth inter-method adjustment proposed for haemodialysis.

  2014influential citation
• LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations

  2014influential citation
• Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH/intact PTH ratio

  2013cites this paper
• PTH--a particularly tricky hormone: why measure it at all in kidney patients?

  2013cites this paper
• Bone and Calcium Metabolism

  2013cites this paper
• Feeding Reduces Serum Concentration of Endogenous Bioactive (1-84), but Not Total Intact Parathyroid Hormone in Female Sprague-Dawley Rats

  2013cites this paper
• A randomised clinical study of alfacalcidol and paricalcitol.

  2012cites this paper
• Nontruncated amino‐terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation

  2011cites this paper
• Influence of Secondary Hyperparathyroidism Induced by Low Dietary Calcium, Vitamin D Deficiency, and Renal Failure on Circulating Rat PTH Molecular Forms

  2011cites this paper
• Comparison of three different immunoassay methods for the evaluation of intact parathyroid hormone levels in hemodialysis patients

  2011cites this paper
• Variation in parathyroid hormone immunoassay results—a critical governance issue in the management of chronic kidney disease

  2011cites this paper
• Optimizing bone health in chronic kidney disease.

  2010cites this paper
• Parathyroid hormone measurement in CKD.

  2010cites this paper
• Restoration of reversed whole PTH/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient.

  2010cites this paper
• Rat parathyroid hormone (rPTH) ELISAs specific for regions (2-7), (22-34) and (40-60) of the rat PTH structure: influence of sex and age.

  2010cites this paper
• Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

  2009cites this paper
• Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

  2009cites this paper
• Actualités sur les dosages de parathormone : des difficultés analytiques à l’interprétation des résultats en clinique

  2009cites this paper
• Diagnosis of Asymptomatic Primary Hyperparathyroidism : Proceedings of the Society

  2009cites this paper
• High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism

  2009cites this paper
• Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment.

  2009cites this paper
• Reversed whole PTH/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review

  2008cites this paper
• Genetic Disorders Caused by PTH/PTHrP Receptor Mutations

  2008cites this paper
• Analytical validation of the new version of the Liaison N-Tact PTH assay

  2007cites this paper
• An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma.

  2007cites this paper
• Stability of intact parathyroid hormone in samples from hemodialysis patients.

  2007cites this paper
• Circulating PTH molecular forms: what we know and what we don't.

  2006cites this paper
• Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.

  2006cites this paper
• Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays.

  2006cites this paper
• Inter-method variability in PTH measurement: implication for the care of CKD patients.

  2006cites this paper
• Practical considerations in PTH testing.

  2006cites this paper
• Measurement of PTH Fragments for Assessment of Renal Bone Disease in Hemodialysis Patients

  2006cites this paper
• Evolution of PTH assays.

  2006cites this paper
• Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.

  2006cites this paper
• Aspects pratiques des dosages de PTH

  2006cites this paper
• Measurement of Parathyroid Hormone

  2006cites this paper
• CHAPTER 30 – Measurement of Parathyroid Hormone

  2006cites this paper
• Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology

  2005cites this paper
• Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.

  2005cites this paper
• Overproduction of an amino‐terminal form of PTH distinct from human PTH(1–84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery

  2005cites this paper
• Effect of obesity on PD versus HD survival: is caloric intake the discriminating factor?

  2004cites this paper